LEADER 07423nam 2200565 450 001 9910483387603321 005 20220701151321.0 010 $a3-030-49885-9 035 $a(CKB)4100000011807060 035 $a(MiAaPQ)EBC6531769 035 $a(Au-PeEL)EBL6531769 035 $a(OCoLC)1244535035 035 $a(PPN)254724426 035 $a(EXLCZ)994100000011807060 100 $a20211016d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAtlas of nuclear cardiology /$fedited by Jagat Narula, Vasken Dilsizian 205 $aFifth edition. 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (542 pages) 311 $a3-030-49884-0 327 $aIntro -- Preface -- Contents -- Contributors -- 1: History of Nuclear Cardiology -- Discovery of Natural Radioactivity: Antoine Henri Becquerel -- Understanding the Nature of Radiation -- First Tracer Study in Humans: Herrmann Blumgart -- The Radiocardiogram: Myron Prinzmetal -- Radionuclide Imaging -- Scintillation Camera: Hal Anger -- Cardiac Studies -- Left Ventricular Ejection Fraction -- Myocardial Perfusion -- References -- 2: Principles of Nuclear Cardiology Imaging -- Introduction -- Fundamentals -- Formation of Radionuclides -- Imaging Devices and Principles -- Quality Control Procedures -- Advances in Cardiology Imaging -- References -- 3: Handling Radionuclides and Radiation Safety -- References -- 4: SPECT and PET Myocardial Perfusion Imaging: Tracers and Techniques -- Myocardial Perfusion, Uptake, and Clearance -- Image Interpretation and Quantitation -- SPECT Techniques: 201TI -- SPECT Techniques: 99mTc-labeled Perfusion Tracers -- PET Tracers and Techniques -- References -- 5: Physiologic and Pharmacologic Stressors -- Introduction -- Physiologic Stress -- Pharmacologic Stress -- Selective Adenosine-2A Receptor Agonists -- Pivotal Regadenoson Clinical Trials -- Selective A2A Receptor Agonist Side Effect Profiles -- Recent Clinical Applications -- Preoperative Cardiac Risk Stratification -- Pharmacologic Stress Myocardial Perfusion Imaging Literature -- Current Clinical Practice Guidelines -- Clinical Utility of Stress Imaging in Perioperative Risk Assessment -- Recent Clinical Applications -- Stress Imaging Modality Choice -- References -- 6: Coronary Physiology and Quantitative Myocardial Perfusion -- Why Coronary Physiology and Quantitative Perfusion? -- Clinical Coronary Physiology -- The Literature: Conflicts, Explanations, Resolutions -- Conflicts: Which Is Best, CFR or Stress Perfusion?. 327 $aConflicts: Which Is Best for Diagnosis of Significant Stenosis, FFRCT or Quantitative PET Perfusion? -- Conflicts: Which Is Best for Diagnosis of Significant Stenosis, CT Angiography (CTA) or Quantitative PET Perfusion? -- Conflicts: What Is the Prevalence of Microvascular Disease? -- Making Physiologic Displays That Are Clinically Useful -- Interacting Clinical Physiology and Imaging Physics -- Clinical Coronary Physiology by PET to Guide Cardiac Care -- Physiologic Severity, Revascularization, and Outcomes -- Quantitative Myocardial Perfusion for Clinical Dilemmas -- Severe CAD Missed on Angiograms -- Recurrent Angina after Surgery -- Progression and Regression of CAD -- The Unmeasured Elephants in Cardiology: Methods Thinking Versus Physiology Thinking -- Subendocardial Perfusion -- Low-Risk Versus High-Risk Angina -- References -- 7: Assessment of Cardiac Function: First-Pass, Equilibrium Blood Pool, and Gated Myocardial SPECT -- Introduction -- Blood Pool Imaging of Ventricular Function -- First-Pass Versus Equilibrium Method -- First-Pass Analysis -- Equilibrium Analysis -- Gating Methods -- Clinical Parameters -- Radionuclide Angiography in Clinical Cardiology -- SPECT Blood Pool Imaging -- Gated Myocardial Perfusion SPECT -- Partial Volume Effect -- Gated Perfusion Imaging -- References -- 8: Prognostic Performance of Myocardial Perfusion and Function -- Introduction -- Pathophysiologic Basis for Risk Assessment in Myocardial Perfusion SPECT -- Differentiating Outcome Type by Nuclear Test Results -- Interpreting Perfusion Data in Conjunction with Pre-test Assessments of Risk -- Clinical Factors and Their Interactions with Ischemia -- The Effect of Changes in SPECT MPI Protocols and Technology -- The Role of Coronary Calcium Scoring -- Using Perfusion Imaging to Assess Survival Benefit from Revascularization -- References. 327 $a9: Imaging Cardiac Metabolism -- Introduction -- Evolution of Knowledge of Cardiac Metabolism -- Metabolic Radiotracers -- Metabolic Signals in Normal and Diseased Heart: Opportunities for Molecular Imaging -- Clinical Application of Myocardial Metabolism: PET and SPECT Techniques -- PET Techniques: 11C-Palmitate -- SPECT Technique: 123I-BMIPP -- PET Technique: 11C-Acetate -- PET and SPECT Techniques: 18F-FDG -- Metabolic Pathways and Patterns -- References -- 10: Myocardial Viability -- Requirements for Cellular Viability -- Pathogenetic Basis of Altered Myocardial States -- Left Ventricular Ejection Fraction -- Evaluating Myocardial Viability -- Arithmetic of Altered Myocardial States -- References -- 11: Myocardial Innervation -- Autonomic Nervous System -- Radiotracers -- Normal Myocardial Innervation -- Heart Failure -- Ischemic Heart Disease -- Atrial and Ventricular Arrhythmias -- Diabetes -- Cardiac Transplantation -- References -- 12: Diagnosis and Risk Stratification in Acute Coronary Syndromes -- Introduction -- General Approach to Cardiovascular Imaging in ACS -- Radionuclide Imaging Early in the Evaluation of Suspected ACS -- Echocardiography in the Evaluation of Suspected ACS -- Cardiac CT Imaging in the Evaluation of Suspected ACS -- Cardiac MRI in the Evaluation of Suspected ACS -- Imaging of Myocardial Salvage in Patients with Acute Myocardial Infarction -- Role of Radionuclide Imaging Following an ACS -- References -- 13: Imaging Cardiac Sarcoidosis, Amyloidosis, and Cardiovascular Prosthetic Infections -- Cardiac Sarcoidosis -- Cardiovascular Prosthetic Infection -- Cardiac Amyloidosis -- References -- 14: Clinical Molecular Imaging of Inflammation and Calcification in Atherosclerosis -- Biology of At?herosclerosis -- Imaging of Cardiovascular Inflammation -- Insights into Clinical Risk -- Imaging Coronary Plaque Inflammation. 327 $aImaging of Vascular Microcalcification -- Gaining Insights Into Treatment Effects -- Multitissue Imaging to Gain Unique Biological Insights in Humans -- Potential Future Clinical Use -- References -- Index. 606 $aHeart$xRadionuclide imaging$vAtlases 606 $aCardiologia$2thub 606 $aMedicina nuclear$2thub 606 $aRadiologia mèdica$2thub 608 $aAtles (Científic)$2thub 608 $aLlibres electrònics$2thub 615 0$aHeart$xRadionuclide imaging 615 7$aCardiologia 615 7$aMedicina nuclear 615 7$aRadiologia mèdica 676 $a616.1207575 702 $aNarula$b Jagat 702 $aDilsizian$b Vasken 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910483387603321 996 $aAtlas of nuclear cardiology$91905220 997 $aUNINA